As the COVID-19 epidemic gradually slows down, various rapid diagnostic test researchers begin to expand their targets to other infectious diseases. In the research and development process, the primary antibody and the secondary antibody are important raw materials. Bio Matrix Research (BMR) and Arista Biologicals, are the leading manufacturers in this field.

BMR from Japan uses their experience and technology in the antibody industry to produce monoclonal antibodies with high affinity and high specificity, which can recognize almost all epitopes on the target. They have been deeply involved in the research and development of infectious diseases for many years. In terms of respiratory, they provide Influenza A, Influenza B, Adenovirus and Respiratory syncytial virus(RSV); for other infectious diseases, they also develop monoclonal antibodies against Dengue virus, Malaria, Zika virus and Mycoplasma pneumoniae.

Arista Biologicals from the United States provides secondary antibodies for rapid diagnostic reagents, and its products include Mouse IgG, Rabbit IgG, Human IgG, Goat IgG and Chicken IgY!

Both the primary antibody and the secondary antibody are important raw materials for the development of rapid diagnostic test. If you have relevant needs or questions, feel free to contact us!